Global Ethics and Compliance
The Global Ethics and Compliance function is responsible for supporting the development and implementation of practices that facilitate compliance with laws and Group policy.
Our Code of Conduct is the foundation of our company policies. It sets out fundamental principles and our GSK Values that staff should apply in their daily work. Underpinning the Code of Conduct is a range of corporate policies providing specific guidance in areas such as competition law, marketing practices, non-discrimination, share dealing and conflicts of interest. It is the responsibility of all staff to follow the Code to sustain the trust and confidence of our stakeholders.
Ask questions, raise concerns, speak up. We will listen and support you. Go to www.gsk.com/speakup
Our GSK Speak Up Integrity Lines are available to report alleged breaches of legal or regulatory obligations, financial fraud (including accounting internal controls and auditing), or any other alleged contravention of GSK's Code of Conduct and company policies.
Issues and concerns can be reported using different communication channels and concerns may be reported anonymously if desired.
A secure, offsite post office box may also be used:
Box 58572
Please do not use the Speak Up Integrity Lines or post office box for product enquiries or to report adverse events. Visit the contact us page for instructions on where to submit questions on these matters.
Ethics and Compliance Overview
See more on Ethics and Compliance.
Find out more about us
-
Governance
At GSK we are committed to operating at the highest standards of corporate governance
-
What we do
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare
-
Responsibility
Responsible business is how we do business. Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer
-
Investors
Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting